Detection of kidney dysfunction potential biomarkers with hypertension in the persons of 25–45 years
- Authors: Kovalkova N.A.1, Khudyakova A.D.1, Kashtanova E.V.1, Polonskaya Y.V.1, Shcherbakova L.V.1, Ragino Y.I.1
-
Affiliations:
- Research Institute of Internal and Preventive Medicine – branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
- Issue: Vol 92, No 12 (2020)
- Pages: 19-24
- Section: Articles
- URL: https://journals.rcsi.science/0040-3660/article/view/60248
- DOI: https://doi.org/10.26442/00403660.2020.12.200436
- ID: 60248
Cite item
Full Text
Abstract
Aim. To assess the significance of symmetrical dimethylarginine (SDMA), uromodulin, retinol-binding protein 4 (RSB-4), transforming growth factor b1 (TGF-b1), plasminogen activator inhibitor 1 (PAI-1) as kidney dysfunction potential biomarkers persons with hypertension in persons 25–45 years old.
Materials and methods. The study included 147 people. Hypertension was recorded with blood pressure (BP)≥140/90 mm Hg, renal dysfunction – with GFRCKD-EPI<90 ml/min/1.73 cm2. Four groups were formed: 1 – individuals with hypertension and GFR<90 ml/min/1.73 cm2; 2 – with hypertension and GFR≥90 ml/min/1.73 cm2; 3 – with BP<140/90 mm Hg and GFR<90 ml/min/1.73 cm2; 4 – with BP<140/90 mm Hg and GFR≥90 ml/min/1.73 cm2. The groups were comparable by gender, age, and number of respondents. Creatinine, SDMA, uromodulin, RSB-4, TGF-b1, PAI-1 levels were examined in all individuals in the serum.
Results. The maximum values of SDMA were determined in the 1st and 3rd groups (1.30 and 1.36 μmol/l). In the 1st group, an association was found between SDMA and GFR (r=-0.324; p=0.048). In the 1st group, the minimum values of uromodulin were recorded, in the 4th group – the maximum values (164.86 and 188.90 ng/ml; at the same time р=0.921). The level of RSB-4 was the highest in the 1st group, the lowest – in the 4th group (88.64 and 80.05 µg/ml; p=0.011). The association of RSB-4 with SDMA in the 3rd group (r=0.400; p=0.017), the 4th group (r=0.403; p=0.018) was detected. The level of TGF-b1 was 1.5 times higher in the 1st group than in the 3rd (23.16 and 15.99 µg/ml; p=0.026), the association of TGF-b1 with GFR in the 1st group had the opposite direction (r=-0.452; p=0.005). The study of similar indicators of PAI-1 did not reveal its relationship with renal dysfunction in hypertension.
Conclusion. The results of the study made it possible to consider SDMA, RSB-4, TGF-b1 as potential biomarkers of renal dysfunction in hypertension in persons 25–45 years old.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
N. A. Kovalkova
Research Institute of Internal and Preventive Medicine – branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
Author for correspondence.
Email: terap2000@yandex.ru
ORCID iD: 0000-0001-5368-1899
к.м.н., ст. науч. сотр.
Russian Federation, NovosibirskA. D. Khudyakova
Research Institute of Internal and Preventive Medicine – branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
Email: terap2000@yandex.ru
ORCID iD: 0000-0001-5397-0498
аспирант
Russian Federation, NovosibirskE. V. Kashtanova
Research Institute of Internal and Preventive Medicine – branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
Email: terap2000@yandex.ru
ORCID iD: 0000-0003-2268-4186
д.б.н., ст. науч. сотр.
Russian Federation, NovosibirskYa. V. Polonskaya
Research Institute of Internal and Preventive Medicine – branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
Email: terap2000@yandex.ru
ORCID iD: 0000-0002-3538-0280
д.б.н., ст. науч. сотр.
Russian Federation, NovosibirskL. V. Shcherbakova
Research Institute of Internal and Preventive Medicine – branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
Email: terap2000@yandex.ru
ORCID iD: 0000-0001-9270-9188
ст. науч. сотр.
Russian Federation, NovosibirskYu. I. Ragino
Research Institute of Internal and Preventive Medicine – branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
Email: terap2000@yandex.ru
ORCID iD: 0000-0002-4936-8362
чл.-кор. РАН, д.м.н., врио руководителя
Russian Federation, NovosibirskReferences
- Чазова И.Е., Жернакова Ю.В., Ощепкова Е.В. и др. Распространенность факторов риска сердечно-сосудистых заболеваний в российской популяции больных артериальной гипертонией. Кардиология. 2014;10:4-12 [Chazova IE, Zhernakova YuV, Oshchepkova EV, et al. Prevalence of Cardiovascular Risk Factors in Russian Population of Patients With Arterial Hypertension. Kardiologiia. 2014;10:4-12 (In Russ.)]. doi: 10.18565/cardio.2014.10.4-12
- Фролов Д.С., Шустов С.Б., Барсуков А.В. и др. Вторичная нефропатия при артериальной гипертензии. Лечение и профилактика. 2015;3(15):39-45 [Frolov DS, Shustov SB, Barsukov AV, et al. The secondary nephropathy under arterial hypertension. Treatment and prevention. 2015;3(15):39-45 (In Russ.)].
- Singer E, Markó L, Paragas N, et al. Neutrophil gelati-nase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf). 2013;4:63-72. doi: 10.1111/apha.12054
- Konrad M. Andrassy. Comments on «KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease». Kidney Int. 2013;3(84):622-3. doi: 10.1038/ki.2013.243
- Ковалькова Н.А., Рагино Ю.И., Худякова А.Д. и др. Уровни артериального давления и распространенность артериальной гипертонии в популяции жителей Центрального региона Сибири в возрасте 25–45 лет. Кардиология. 2019;59(2):32-7 [Kovalkova NA, Ragino YI, Hudyakovа AD, et al. Blood Pressure Levels and Prevalence of Arterial Hypertension in the Population of Residents of the Central Region of Siberia Aged 25–45 Years. Kardiologiia. 2019;59(2):32-7 (In Russ.)]. doi: 10.18087/cardio.2019.2.10228
- Смирнов А.В., Шилов Е.М., Добронравов В.А. и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Нефрология. 2012;16(1):89-115 [Smirnov AV, Shilov EM, Dobronravov VA, et al. National guidelines. Chronic kidney disease: basic principles of screening, diagnosis, prevention and treatment approaches. Nephrology. 2012;16(1):89-115 (In Russ.)]. doi: 10.24884/1561-6274-2012-16-1-89-115
- Schepers E, Barreto DV, Liabeuf S, et al. Symmetric Dimethylarginine as a Proinflammatory Agent in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2011;6(10):2374-83. doi: 10.2215/CJN.01720211
- Kielstein JT, Salpeter SR, Bode-Boeger SM, et al. Symmetric dimethylarginine as endogenous marker of renal function – a meta-analysis. Nephrol. Dial. Transplant. 2006;21(9):2446-51. doi: 10.1093/ndt/gfl292
- Thongboonkerd V. Study of diabetic nephropathy in the proteomic era. Contrib Nephrol. 2011;170:172-83.
- Fliser D, Kronenberg F, Kielstein JT, et al. Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study. J Am Soc Nephrol. 2005;16:2456-61. doi: 10.1681/ASN.2005020179
- Смирнов А.В., Хасун М., Каюков И.Г. и др. Уромодулин и выраженность тубулоинтерстициальных повреждений у пациентов с нефропатиями. Нефрология. 2015;19(2):49-54 [Smirnov AV, Hasun M, Kayukov IG, et al. Uromodulin and severity of tubulointerstitial lesions in patients with nephropathies. Nefrologiya. 2015;19(2):49-54 (In Russ.)]. doi: 10.26442/terarkh201890641-47
- Steubl D, Block M, Herbst H, et al. Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney disease patients. Medicine. 2016;95:3011. doi: 10.1097/MD.0000000000003011
- Scherberich JE, Gruber R, Nockher WA, et al. Serum uromodulin – a marker of kidney function and renal parenchymal integrity. Nephrol Dial Transplant. 2018;33(2):284-95. doi: 10.1093/ndt/gfw422
- Bobbert T, Raila J, Schwarz F, et al. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis. 2010;213:549-51. doi: 10.1016/j.atherosclerosis.2010.07.063
- Henze A, Frey SK, Raila J, et al. Alterations of retinol-binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters. Biochem Biophys Res Commun. 2010;393(1):79-83. doi: 10.1016/j.bbrc.2010.01.082
- Frey SK, Nagl B, Henze A, et al. Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipids Health Dis. 2008;7:29. doi: 10.1186/1476-511X-7-29
- Malgorzewicz S, Skrzypczak-Jankun E, Jankun J. Plasminogen activator inhibitor-1 in kidney pathology. Int J Mol Med. 2013;31:503-10. doi: 10.1111/jcmm
- Scaglione R, Argano C, Chiara T, et al. Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. Blood Press. 2003;12(5-6):269-76. doi: 10.1080/08037050310016484
- Suthanthiran M, Gerber LM, Schwartz JE, et al. Circulating transformind growth factor-b1 levels and the risk for kidney disease in African Americans. Kidney Int. 2009;7:72-80. doi: 10.1038/ki.2009.66